Docteur Philippe MERTZ
57 publis sur 5 ans↗
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
📝 Autres formations
- Allergologie et Immunologie clinique
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
17
h articles cités ≥ h fois chacun. Un h de 17 = 17 publications avec 17+ citations.
Citations
841
Publications
82
i10-index
21
Thématiques principales
- Systemic Lupus Erythematosus Research ×19
- Inflammasome and immune disorders ×14
- Otitis Media and Relapsing Polychondritis ×10
- Vasculitis and related conditions ×8
- Vascular Anomalies and Treatments ×8
Affiliations FR : Centre National de la Recherche Scientifique · Inserm · Université Paris Cité
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice
2025ArticleEMBO Molecular Medicine
Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients
2025ArticleEuropean Journal of Internal Medicine
New Diseases Linked to MEFV Variants or Pyrinopathies
2025ArticleJournal of Allergy and Clinical Immunology: In Practice
Performance of serum IL-18 levels for the follow-up of patients with familial Mediterranean fever
2025ArticleJournal of Allergy and Clinical Immunology: In Practice
Current landscape of monogenic autoinflammatory actinopathies: A literature review
2025ArticleAutoimmunity Reviews
Maladies auto-inflammatoires associées à l’IL-18
2024ArticleLa Revue de Médecine Interne
Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event
2024ArticleRheumatology
Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management
2021ArticleJournal of Clinical Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Livres & ouvrages
- 📕
Fatigue is Independently Associated with Disease Activity Assessed Using the Physician Global Assessment But Not the SLEDAI in Patients with Systemic Lupus Erythematosus
20220
avec Matteo Piga, Elisabetta Chessa et al.
- 📕
Lupus induits
analyse de 12166 cas dans la base de pharmacovigilance de l'Organisation Mondiale de la Santé
20200
- 📕
Handicap, douleur, mort, soins palliatifs, accompagnement, anesthésie, médecine
du travail, médecine
2018 · 170 p.
- 📕
Médicaments, pharmacologie, thérapeutique
2018 · 180 p.
- 📕
Neurologie, gériatrie, psychiatrie
Fiches pour l'iECN
2017 · 306 p.
- 📕
Urgence, réanimation, traumatologie, orthopédie
Fiches pour l'iECN
2017 · 379 p.
Source : Google Books — filtre catégories médicales/santé/sciences.
Lieu de consultation
GHU APHP SUN SITE TENON
4 Rue DE LA CHINE, 75970 Paris 20e Arrondissement
☎ 0156017000Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production
The Journal of biological chemistry · 1994
📚 160 citations🎯 RCR 4.29Top 10% NIH - 2Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014
Autoimmunity reviews · 2020
📚 111 citations🎯 RCR 5.86Top 6% NIH - 3Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database
Annals of the rheumatic diseases · 2019
📚 55 citations🎯 RCR 2.79Top 18% NIH🩺 Clinique
Publications scientifiques (43) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal22
▼
Transversal22
▼- Colchicine resistance prediction criteria from the TURPAID cohort do not apply to the JIR cohort: a multicentre descriptive analysis
RMD open · 2026 · Journal Article
Mertz P, Elhani I, Koné-Paut I, Dan D, et al.
- Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice
EMBO molecular medicine · 2025 · Journal Article
Freytag D, Giorgiutti S, Hopsomer G, Wadier N, et al.
- Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients
European journal of internal medicine · 2025 · Journal Article
Elhani I, Calas L, Bejar F, Fautrel B, et al.
📚 8 cit.🎯 RCR 3.36 - European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)
Orphanet journal of rare diseases · 2025 · Journal Article
Arnaud L, Sander O, Rednic S, Mertz P, et al.
📚 3 cit. - New Diseases Linked to MEFV Variants or Pyrinopathies
The journal of allergy and clinical immunology. In practice · 2025 · Journal Article
Mertz P, Boursier G, Hentgen V, Georgin-Lavialle S
📚 6 cit.🎯 RCR 2.64 - Performance of serum IL-18 levels for the follow-up of patients with familial Mediterranean fever
The journal of allergy and clinical immunology. In practice · 2025 · Journal Article
Elhani I, Calas L, Bejar F, Pieroni L, et al.
📚 3 cit. - Relapsing polychondritis: clinical updates and new differential diagnoses
Nature reviews. Rheumatology · 2024 · Journal Article
Mertz P, Costedoat-Chalumeau N, Ferrada MA, Moulis G, et al.
📚 27 cit.🎯 RCR 8.98 - Clinical images: Calabar swelling caused by Loa loa mimicking polyarthritis
Rheumatology (Oxford, England) · 2024 · Journal Article
Jannot X, Gerber V, Hallynck X, Willaume T, et al.
- Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)
Joint bone spine · 2024 · Review
Mathian A, Felten R, Alarcon-Riquelme ME, Psarras A, et al.
📚 20 cit.🎯 RCR 4.69 - Rheumatoid vasculitis in 2023: Changes and challenges since the biologics era
Autoimmunity reviews · 2023 · Journal Article
Mertz P, Wollenschlaeger C, Chasset F, Dima A, et al.
📚 24 cit.🎯 RCR 4.66 - Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases
Drug discovery today · 2023 · Journal Article
Felten R, Mertz P, Sebbag E, Scherlinger M, et al.
📚 18 cit.🎯 RCR 1.72 - [Restatement. Relapsing polychondritis]
La Revue du praticien · 2023 · English Abstract
Mertz P, Arnaud L
- Relapsing polychondritis: Best Practice & Clinical Rheumatology
Best practice & research. Clinical rheumatology · 2023 · Journal Article
Mertz P, Sparks J, Kobrin D, Ogbonnaya SA, et al.
📚 10 cit.🎯 RCR 1.56 - Bilateral gastrocnemius myositis: an extra-intestinal manifestation of Crohn's disease
Rheumatology (Oxford, England) · 2022 · Case Reports
Mertz P, Lannes B, Nadaj Pakleza A, Meyer A, et al.
📚 2 cit. - Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?
Autoimmunity reviews · 2021 · Letter
Mertz P, Jeannel J, Guffroy A, Lescuyer S, et al.
📚 19 cit.🎯 RCR 1.38 - Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases
Haematologica · 2021 · Letter
Mertz P, Chalayer E, Amoura Z, Cathebras P, et al.
📚 13 cit.🎯 RCR 1.04 - Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database
Autoimmunity reviews · 2021 · Letter
Kawka L, Mertz P, Chasset F, Lebrun-Vignes B, et al.
📚 3 cit. - Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014
Autoimmunity reviews · 2020 · Journal Article
Scherlinger M, Mertz P, Sagez F, Meyer A, et al.
📚 111 cit.🎯 RCR 5.86🔬→🩺 Translationnel - The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis
Joint bone spine · 2019 · Journal Article
Mertz P, Belot A, Cervera R, Chuah TY, et al.
📚 10 cit. - Characterizing drug-induced capillary leak syndromes using the World Health Organization VigiBase
The Journal of allergy and clinical immunology · 2019 · Letter
Mertz P, Lebrun-Vignes B, Salem JE, Arnaud L
📚 29 cit.🎯 RCR 1.61🩺 Clinique - Persistent Acrocyanosis-A Rare Manifestation Revealing Anti-PL-12 Syndrome
Arthritis & rheumatology (Hoboken, N.J.) · 2018 · Journal Article
Mertz P, Herber M, Jeannel J, Korganow AS, et al.
📚 3 cit. - Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production
The Journal of biological chemistry · 1994 · Journal Article
Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM
📚 160 cit.🎯 RCR 4.29🔬→🩺 Translationnel
Lupus10
▼
Lupus10
▼- Levels of physical activity in a large international cohort of patients with systemic lupus erythematosus
Lupus science & medicine · 2025 · Journal Article
Mischler T, Kawka L, Sarmiento-Monroy JC, Mertz P, et al.
📚 1 cit. - Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study
RMD open · 2023 · Journal Article
Kawka L, Sarmiento-Monroy JC, Mertz P, Pijnenburg L, et al.
📚 6 cit.🎯 RCR 1.36 - New and future therapies: Changes in the therapeutic armamentarium for SLE
Best practice & research. Clinical rheumatology · 2023 · Journal Article
Askanase A, Khalili L, Tang W, Mertz P, et al.
📚 19 cit.🎯 RCR 2.10🔬→🩺 Translationnel - New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review
Joint bone spine · 2023 · Systematic Review
Felten R, Scherlinger M, Mertz P, Chasset F, et al.
📚 40 cit.🎯 RCR 4.99🔬→🩺 Translationnel - Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus
RMD open · 2022 · Journal Article
Mertz P, Piga M, Chessa E, Amoura Z, et al.
📚 9 cit.🎯 RCR 1.19 - Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?
Annals of the rheumatic diseases · 2022 · Letter
Mertz P, Arnaud L
- Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management
Journal of clinical medicine · 2021 · Journal Article
Kawka L, Schlencker A, Mertz P, Martin T, et al.
📚 30 cit.🎯 RCR 2.84🔬→🩺 Translationnel - Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus
Rheumatology (Oxford, England) · 2021 · Journal Article
Arnaud L, Mertz P, Amoura Z, Voll RE, et al.
📚 24 cit.🎯 RCR 2.28 - Towards a practical management of fatigue in systemic lupus erythematosus
Lupus science & medicine · 2020 · Journal Article
Mertz P, Schlencker A, Schneider M, Gavand PE, et al.
📚 20 cit.🎯 RCR 1.50 - Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database
Annals of the rheumatic diseases · 2019 · Journal Article
Arnaud L, Mertz P, Gavand PE, Martin T, et al.
📚 55 cit.🎯 RCR 2.79🩺 Clinique
Anti-TNF2
▼
Anti-TNF2
▼- Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study
Autoimmunity reviews · 2020 · Clinical Trial
Mertz P, Kleinmann JF, Lambert M, Puéchal X, et al.
📚 18 cit.🎯 RCR 1.23🩺 Clinique - Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBase
Autoimmunity reviews · 2020 · Journal Article
Vollmer O, Felten R, Mertz P, Lebrun-Vignes B, et al.
📚 24 cit.🎯 RCR 1.29🔬→🩺 Translationnel
Fièvres auto-inflammatoires2
▼
Fièvres auto-inflammatoires2
▼- [What is an undifferentiated systemic autoinflammatory disease in adults? Current state of knowledge in 2025]
La Revue de medecine interne · 2025 · English Abstract
Mertz P, Chauffier J, Delplanque M, Grandpeix-Guyodo C, et al.
- [Autoinflammatory diseases associated with IL-18]
La Revue de medecine interne · 2025 · English Abstract
Mertz P, Hentgen V, Boursier G, Elhani I, et al.
📚 2 cit.
Biothérapies non-anti-TNF1
▼
Biothérapies non-anti-TNF1
▼- Could tocilizumab be used in familial Mediterranean fever? A systematic review
Rheumatology (Oxford, England) · 2025 · Journal Article
Mertz P, Hentgen V, Georgin-Lavialle S
📚 5 cit.🎯 RCR 2.14
Épidémiologie & registres1
▼
Épidémiologie & registres1
▼- Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · Journal Article
Debrut L, Giannini M, Klein D, Spielmann L, et al.
📚 8 cit.🎯 RCR 1.29
Goutte1
▼
Goutte1
▼- [The kidney in gout and gout of the kidney]
Deutsches medizinisches Journal · 1968 · Journal Article
Mertz P
Pharmacovigilance1
▼
Pharmacovigilance1
▼- Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event
Rheumatology (Oxford, England) · 2024 · Case Reports
Sztejkowski C, Sibilia J, Danion F, Mertz P, et al.
Qualité de vie / PROMs1
▼
Qualité de vie / PROMs1
▼- Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument
Orphanet journal of rare diseases · 2026 · Journal Article
Mertz P, Sander O, Faria R, Crisafulli F, et al.
Revue / méta-analyse1
▼
Revue / méta-analyse1
▼- Primary immunodeficiencies and lymphoma: a systematic review of literature
Leukemia & lymphoma · 2020 · Journal Article
Herber M, Mertz P, Dieudonné Y, Guffroy B, et al.
📚 25 cit.🎯 RCR 1.63
Revue générale1
▼
Revue générale1
▼- Primary immunodeficiencies and lymphoma: a systematic review of literature
Leukemia & lymphoma · 2020 · Journal Article
Herber M, Mertz P, Dieudonné Y, Guffroy B, et al.
📚 25 cit.🎯 RCR 1.63
Sjögren1
▼
Sjögren1
▼- c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome
The Journal of rheumatology · 1992 · Journal Article
Skopouli FN, Kousvelari EE, Mertz P, Jaffe ES, et al.
📚 39 cit.🎯 RCR 1.01
Vascularites des gros vaisseaux1
▼
Vascularites des gros vaisseaux1
▼- Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study
Autoimmunity reviews · 2020 · Clinical Trial
Mertz P, Kleinmann JF, Lambert M, Puéchal X, et al.
📚 18 cit.🎯 RCR 1.23🩺 Clinique
Datasets & protocoles partagés
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument
Collection2026figshareAbstract Introduction Relapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation of cartilaginous structures and a broad spectrum of systemic features. To date, no Health-related
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument
Collection2026figshareAbstract Introduction Relapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation of cartilaginous structures and a broad spectrum of systemic features. To date, no Health-related
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)
Collection2025figshareAbstract The traditional process of intercultural adaptation, while suitable for one or a few target languages, is not optimal for developing instruments for rare connective tissue diseases (CTDs) in multiple languages s
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)
Collection2025figshareAbstract The traditional process of intercultural adaptation, while suitable for one or a few target languages, is not optimal for developing instruments for rare connective tissue diseases (CTDs) in multiple languages s
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).